Company profile for Accord healthcare

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

With an extensive presence in North America, Europe, South America, Australia, New Zealand and South Africa and more recently in the MENA region, Accord Healthcare has very rapidly become one of the fastest growing generic pharmaceutical companies. With a robust product portfolio in growth oriented therapies, such as Oncology, Cardiology, Neurology, Nephrology, Urology, Psychiatry, Diabetology, Pain management and Gastroentero...
With an extensive presence in North America, Europe, South America, Australia, New Zealand and South Africa and more recently in the MENA region, Accord Healthcare has very rapidly become one of the fastest growing generic pharmaceutical companies. With a robust product portfolio in growth oriented therapies, such as Oncology, Cardiology, Neurology, Nephrology, Urology, Psychiatry, Diabetology, Pain management and Gastroenterology and over 4000 product approvals (as of June, 2013) in various markets, Accord’s sales, marketing and distribution network now reaches over 60 countries.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
Sage House, 319 Pinner Road North Harrow HA1 4HF
Telephone
Telephone
+44 (0) 208 863 1427
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219406

FDA
03 Oct 2025

https://www.prnewswire.com/news-releases/accord-healthcare-launches-dehydrated-alcohol-injection-for-cardiovascular-indications-302490056.html

PR NEWSWIRE
25 Jun 2025

https://www.prnewswire.com/news-releases/accord-healthcare-recibe-la-aprobacion-para-hetronifly-de-la-mhra-para-el-tratamiento-de-es-sclc-302489491.html

PR NEWSWIRE
24 Jun 2025

https://www.prnewswire.com/news-releases/accord-healthcare-receives-approval-for-hetronifly-serplulimab-from-the-medicines-and-healthcare-regulatory-agency-mhra-for-first-line-treatment-of-extensive-stage-small-cell-lung-cancer-es-sclc-302488662.html

PR NEWSWIRE
24 Jun 2025

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217845

FDA
23 Jun 2025

https://www.ema.europa.eu/en/documents/overview/osvyrti-epar-medicine-overview_en.pdf

EMA
26 May 2025

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Accord healthcare and get a quotation

Accord healthcare is a supplier offers 2 products (APIs, Excipients or Intermediates).

Find a price of Docetaxel bulk offered by Accord healthcare

Find a price of Paclitaxel bulk offered by Accord healthcare

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty